Hancock Jaffe Laboratories Inc IPO year
What is the IPO year of Hancock Jaffe Laboratories Inc?
The IPO year of Hancock Jaffe Laboratories Inc is 1970
What is the definition of IPO year?
Initial public offering is a type of public offering in which shares of a company usually are sold to institutional investors that in turn, sell to the general public, on a securities exchange, for the first time.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
IPO year of companies in the Health Care sector on NASDAQ compared to Hancock Jaffe Laboratories Inc
What does Hancock Jaffe Laboratories Inc do?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Companies with ipo year similar to Hancock Jaffe Laboratories Inc
- Vanguard FTSE Developed Europe ex UK ETF has IPO year of 1969
- Hancock Jaffe Laboratories Inc has IPO year of 1970
- PepsiCo Inc has IPO year of 1972
- Applied Materials has IPO year of 1972
- L&T Finance has IPO year of 1972
- Coca-Cola Consolidated Inc has IPO year of 1972
- GT Biopharma has IPO year of 1972
- Jacobs Solutions Inc has IPO year of 1972